GKCAS 2018 Annual Allergy & Immunology Symposium

Overland Park, KS US
January 20, 2018

Didactic lectures allow the speakers to provide evidence based medical recommendations, updates and expert opinion in an efficient manner held in a one day meeting.

Target Audience

Practicing allergists, physicians and allied health professionals.

Learning Objectives

Upon completion of this session, participants should be able to:

• Distinguish between patients who will benefit from traditional treatment modalities versus the addition of a biologic to manage their atopic dermatitis.

• Identify the appropriate treatment modality for each individual patient and what patient profile would benefit from consideration for treatment with a biologic.

• Recommend, via counseling, the appropriate treatment modality, including consideration for treatment with a biologic, based on the evidence based management approach along with patient preference and potential adverse effects.

• Recommend strategies for long-term monitoring when using biologic therapies.

Additional information
Disclosure: 

Disclosure Policy
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Mariana Castells, MD

Consultant: Sanofi, Contrafect, Bentham Sciences, Insys

Advisory Board Member: Merck

Luz Fonacier, MD

Contracted Research: Genentech

Speaker Honorarium: Regeneron

Matt Greenhawt, MD

Consultant: Aimmune, Intromune, Thermo Fisher Scientific

Advisory Board Member: Kaléo, Nestle Nutrition Institute, Monsanto

Speaker: Thermo Fisher Scientific

The following have no financial relationships to disclose:

Sadia Hayat, MD

Nikita Raje, MD

Mamta Reddy, MD, MBOE

Nguyen Tran, MD

James Verbsky, MD

Kristen Welborn, RN, MSN, FNP-C

Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Course opens: 
01/20/2018
Course expires: 
01/20/2020
Event starts: 
01/20/2018 - 7:15am
Event ends: 
01/20/2018 - 1:15pm
Cost:
$0.00
Rating: 
0
Ritz Charles
9000 W. 137th Street
Overland Park, KS 66221
United States
+1 (913) 685-2600

Accreditation  

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Greater Kansas City Allergy Society (GKCAS).  The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance

Accreditation Period

Course opens: 
01/20/2018
Course expires: 
01/20/2020

Price

Cost:
$0.00
Please login or create an account to take this course.